Cargando…

Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention

Respiratory viral infections (RVIs) are of major clinical importance in immunocompromised patients and represent a substantial cause of morbidity and mortality in patients with hematologic malignancies and those who have undergone hematopoietic cell transplantation. Similarly, patients receiving imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson Dib, Rita, Ariza-Heredia, Ella, Spallone, Amy, Chemaly, Roy F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096899/ https://www.ncbi.nlm.nih.gov/pubmed/37065990 http://dx.doi.org/10.1093/ofid/ofad166

Ejemplares similares

Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes
por: Spallone, Amy, et al.
Publicado: (2022)

2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
por: Daher, Marilyne, et al.
Publicado: (2022)

922. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis
por: Spallone, Amy, et al.
Publicado: (2021)

1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes
por: Febres-Aldana, Anthony J, et al.
Publicado: (2023)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018)

15. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies
por: Angelidakis, Georgios, et al.
Publicado: (2021)

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Artau, Annette, et al.
Publicado: (2018)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
por: El Chaer, Firas, et al.
Publicado: (2022)

2798. Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infection and Mortality
por: Martinez, Daniel De La Rosa, et al.
Publicado: (2019)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
por: Khawaja, Fareed, et al.
Publicado: (2022)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

580. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
por: Sassine, Joseph, et al.
Publicado: (2020)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned
por: Khawaja, Fareed, et al.
Publicado: (2023)

Transplant Providers’ Perceptions of COVID-19 Vaccination in the Wake of a Global Pandemic
por: Spallone, Amy, et al.
Publicado: (2022)

2681. Outcomes Related to Respiratory Viral Infections in Cancer Patients on PD-1 Inhibitors
por: Khawaja, Fareed, et al.
Publicado: (2019)

Clinical and Economic Burden of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients: The MD Anderson Experience
por: Ghantoji, Shashank S, et al.
Publicado: (2017)

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
por: Khawaja, Fareed, et al.
Publicado: (2019)

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies
por: Vakil, Erik, et al.
Publicado: (2018)

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes
por: El Chaer, Firas, et al.
Publicado: (2017)

1914. Characteristics of Hospital Onset SARS Cov-2 Infections Before and After the Emergence of The Highly Transmissible Variant B.1.1.529 In a Comprehensive Cancer Center
por: Dib, Rita Wilson, et al.
Publicado: (2022)

Utility of the Enzyme-Linked Immunospot Interferon-γ–Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2016)

Frequently Asked Questions about Mpox (Formerly Monkeypox Disease) for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Recipients from the American Society for Transplantation and Cellular Therapy
por: Ford, Emily S., et al.
Publicado: (2023)

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
por: Waghmare, Alpana, et al.
Publicado: (2020)

Respiratory Viral Infections in Transplant Recipients
por: Liu, Catherine, et al.
Publicado: (2018)

Editorial: Immune response to respiratory viruses and respiratory viral infections in susceptible populations
por: Fragkou, Paraskevi C., et al.
Publicado: (2023)

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center
por: Ariza-Heredia, Ella J., et al.
Publicado: (2020)

Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study
por: Magira, Eleni E, et al.
Publicado: (2019)

789. Comparison of Interferon-γ Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients
por: Kulkarni, Prathit, et al.
Publicado: (2018)

Corrigendum: Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients With Hematologic Malignancies: A Case-Control Study
por: Magira, Eleni E, et al.
Publicado: (2019)

355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
por: Magira, Eleni, et al.
Publicado: (2018)

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)
por: Dioverti, Veronica, et al.
Publicado: (2022)

Universal use of surgical masks is tolerated and prevents respiratory viral infection in stem cell transplant recipients
por: Partridge, D.G., et al.
Publicado: (2022)

Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014
por: Kmeid, Joumana, et al.
Publicado: (2019)

Prophylaxis, therapy and prevention of viral respiratory infections
por: Kafetzis, Dimitris A.
Publicado: (2004)

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Ariza-Heredia, Ella J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jd67vgp465fhr0dgpedph9afae